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By Min Qian and Susan A. Murphy
University of Michigan
Because many illnesses show heterogeneous response to treat-
ment, there is increasing interest in individualizing treatment to pa-
tients [Arch. Gen. Psychiatry 66 (2009) 128–133]. An individualized
treatment rule is a decision rule that recommends treatment accord-
ing to patient characteristics. We consider the use of clinical trial
data in the construction of an individualized treatment rule leading
to highest mean response. This is a difficult computational problem
because the objective function is the expectation of a weighted indica-
tor function that is nonconcave in the parameters. Furthermore, there
are frequently many pretreatment variables that may or may not be
useful in constructing an optimal individualized treatment rule, yet
cost and interpretability considerations imply that only a few vari-
ables should be used by the individualized treatment rule. To address
these challenges, we consider estimation based on l1-penalized least
squares. This approach is justified via a finite sample upper bound on
the difference between the mean response due to the estimated indi-
vidualized treatment rule and the mean response due to the optimal
individualized treatment rule.
1. Introduction. Many illnesses show heterogeneous response to treat-
ment. For example, a study on schizophrenia [12] found that patients who
take the same antipsychotic (olanzapine) may have very different responses.
Some may have to discontinue the treatment due to serious adverse events
and/or acutely worsened symptoms, while others may experience few if any
adverse events and have improved clinical outcomes. Results of this type
have motivated researchers to advocate the individualization of treatment
to each patient [11, 16, 23]. One step in this direction is to estimate each pa-
tient’s risk level and then match treatment to risk category [5, 6]. However,
this approach is best used to decide whether to treat; otherwise it assumes
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the knowledge of the best treatment for each risk category. Alternately, there
is an abundance of literature focusing on predicting each patient’s prognosis
under a particular treatment [10, 28]. Thus, an obvious way to individual-
ize treatment is to recommend the treatment achieving the best predicted
prognosis for that patient. In general, the goal is to use data to construct
individualized treatment rules that, if implemented in future, will optimize
the mean response.
Consider data from a single stage randomized trial involving several active
treatments. A first natural procedure to construct the optimal individual-
ized treatment rule is to maximize an empirical version of the mean response
over a class of treatment rules (assuming larger responses are preferred). As
will be seen, this maximization is computationally difficult because the mean
response of a treatment rule is the expectation of a weighted indicator that
is noncontinuous and nonconcave in the parameters. To address this chal-
lenge, we make a substitution. That is, instead of directly maximizing the
empirical mean response to estimate the treatment rule, we use a two-step
procedure that first estimates a conditional mean and then from this esti-
mated conditional mean derives the estimated treatment rule. As will be
seen in Section 3, even if the optimal treatment rule is contained in the
space of treatment rules considered by the substitute two-step procedure,
the estimator derived from the two-step procedure may not be consistent.
However, if the conditional mean is modeled correctly, then the two-step
procedure consistently estimates the optimal individualized treatment rule.
This motivates consideration of rich conditional mean models with many
unknown parameters. Furthermore, there are frequently many pretreatment
variables that may or may not be useful in constructing an optimal indi-
vidualized treatment rule, yet cost and interpretability considerations imply
that fewer rather than more variables should be used by the treatment rule.
This consideration motivates the use of l1-penalized least squares (l1-PLS).
We propose to estimate an optimal individualized treatment rule using
a two step procedure that first estimates the conditional mean response
using l1-PLS with a rich linear model and second, derives the estimated
treatment rule from estimated conditional mean. For brevity, throughout,
we call the two step procedure the l1-PLS method. We derive several finite
sample upper bounds on the difference between the mean response to the
optimal treatment rule and the mean response to the estimated treatment
rule. All of the upper bounds hold even if our linear model for the condi-
tional mean response is incorrect and to our knowledge are, up to constants,
the best available. We use the upper bounds in Section 3 to illuminate the
potential mismatch between using least squares in the two-step procedure
and the goal of maximizing the mean response. The upper bounds in Sec-
tion 4.1 involve a minimized sum of the approximation error and estimation
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error; both errors result from the estimation of the conditional mean re-
sponse. We shall see that l1-PLS estimates a linear model that minimizes
this approximation plus estimation error sum among a set of suitably sparse
linear models.
If the part of the model for the conditional mean involving the treatment
effect is correct, then the upper bounds imply that, although a surrogate
two-step procedure is used, the estimated treatment rule is consistent. The
upper bounds provide a convergence rate as well. Furthermore, in this set-
ting, the upper bounds can be used to inform how to choose the tuning
parameter involved in the l1 penalty to achieve the best rate of convergence.
As a by-product, this paper also contributes to existing literature on l1-PLS
by providing a finite sample prediction error bound for the l1-PLS estimator
in the random design setting without assuming the model class contains or
is close to the true model.
The paper is organized as follows. In Section 2, we formulate the decision
making problem. In Section 3, for any given decision, that is, individualized
treatment rule, we relate the reduction in mean response to the excess pre-
diction error. In Section 4, we estimate an optimal individualized treatment
rule via l1-PLS and provide a finite sample upper bound on the reduction
in mean response achieved by the estimated rule. In Section 5, we con-
sider a data dependent tuning parameter selection criterion. This method
is evaluated using simulation studies and illustrated with data from the
Nefazodone-CBASP trial [13]. Discussions and future work are presented in
Section 6.
2. Individualized treatment rules. We use upper case letters to denote
random variables and lower case letters to denote values of the random vari-
ables. Consider data from a randomized trial. On each subject, we have the
pretreatment variables X ∈ X , treatment A taking values in a finite, discrete
treatment space A, and a real-valued response R (assuming large values are
desirable). An individualized treatment rule (ITR) d is a deterministic deci-
sion rule from X into the treatment space A.
Denote the distribution of (X,A,R) by P . This is the distribution of the
clinical trial data; in particular, denote the known randomization distribu-
tion of A given X by p(·|X). The likelihood of (X,A,R) under P is then
f0(x)p(a|x)f1(r|x,a), where f0 is the unknown density of X and f1 is the
unknown density of R conditional on (X,A). Denote the expectations with
respect to the distribution P by an E. For any ITR d :X →A, let P d de-
note the distribution of (X,A,R) in which d is used to assign treatments.
Then the likelihood of (X,A,R) under P d is f0(x)1a=d(x)f1(r|x,a). Denote
expectations with respect to the distribution P d by an Ed. The Value of d is
defined as V (d),Ed(R). An optimal ITR, d0, is a rule that has the maximal
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Value, that is,
d0 ∈ argmax
d
V (d),
where the argmax is over all possible decision rules. The Value of d0, V (d0),
is the optimal Value.
Assume P [p(a|X) > 0] = 1 for all a ∈ A (i.e., all treatments in A are
possible for all values of X a.s.). Then P d is absolutely continuous with
respect to P and a version of the Radon–Nikodym derivative is dP d/dP =
1a=d(x)/p(a|x). Thus, the Value of d satisfies
V (d) =Ed(R) =
∫
RdP d =
∫
R
dP d
dP
dP =E
[
1A=d(X)
p(A|X) R
]
.(2.1)
Our goal is to estimate d0, that is, the ITR that maximizes (2.1), using data
from distribution P . When X is low dimensional and the best rule within
a simple class of ITRs is desired, empirical versions of the Value can be used
to construct estimators [22, 26]. However, if the best rule within a larger
class of ITRs is of interest, these approaches are no longer feasible.
Define Q0(X,A),E(R|X,A) [Q0(x,a) is sometimes called the “Quality”
of treatment a at observation x]. It follows from (2.1) that for any ITR d,
V (d) =E
[
1A=d(X)
p(A|X)Q0(X,A)
]
=E
[∑
a∈A
1d(X)=aQ0(X,a)
]
=E[Q0(X,d(X))].
Thus, V (d0) =E[Q0(X,d0(X))]≤E[maxa∈AQ0(X,a)]. On the other hand,
by the definition of d0,
V (d0)≥ V (d)|d(X)∈argmaxa∈AQ0(X,a) =E
[
max
a∈A
Q0(X,a)
]
.
Hence, an optimal ITR satisfies d0(X) ∈ argmaxa∈A Q0(X,a) a.s.
3. Relating the reduction in Value to excess prediction error. The above
argument indicates that the estimated ITR will be of high quality (i.e., have
high Value) if we can estimate Q0 accurately. In this section, we justify
this by providing a quantitative relationship between the Value and the
prediction error.
Because A is a finite, discrete treatment space, given any ITR, d, there
exists a square integrable function Q :X × A → R for which d(X) ∈
argmaxaQ(X,a) a.s. Let L(Q) , E[R − Q(X,A)]2 denote the prediction
error of Q (also called the mean quadratic loss). Suppose that Q0 is square
integrable and that the randomization probability satisfies p(a|x)≥ S−1 for
an S > 0 and all (x,a) pairs. Murphy [21] showed that
V (d0)− V (d)≤ 2S1/2[L(Q)−L(Q0)]1/2.(3.1)
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Intuitively, this upper bound means that if the excess prediction error of Q
[i.e., L(Q)− L(Q0)] is small, then the reduction in Value of the associated
ITR d [i.e., V (d0)− V (d)] is small. Furthermore, the upper bound provides
a rate of convergence for the Value of an estimated ITR. For example, sup-
pose Q0 is linear, that is, Q0 = Φ(X,A)θ0 for a given vector-valued basis
function Φ on X ×A and an unknown parameter θ0. And suppose we use
a correct linear model for Q0 (here “linear” means linear in parameters),
say the model Q= {Φ(X,A)θ :θ ∈Rdim(Φ)} or a linear model containing Q
with dimension of parameters fixed in n. If we estimate θ by least squares
and denote the estimator by θˆ, then the prediction error of Qˆ = Φθˆ con-
verges to L(Q0) at rate 1/n under mild regularity conditions. This together
with inequality (3.1) implies that the Value obtained by the estimated ITR,
dˆ(X) ∈ argmaxa Qˆ(X,a), will converge to the optimal Value at rate at least
1/
√
n.
In the following theorem, we improve this upper bound in two aspects.
First, we show that an upper bound with exponent larger than 1/2 can be
obtained under a margin condition, which implicitly implies a faster rate of
convergence. Second, it turns out that the upper bound need only depend
on one term in the function Q; we call this the treatment effect term T . For
any square integrable Q, the associated treatment effect term is defined as
T (X,A) , Q(X,A) − E[Q(X,A)|X]. Note that d(X) ∈ argmaxa T (X,a) =
argmaxaQ(X,a) a.s. Similarly, the true treatment effect term is given by
T0(X,A),Q0(X,A)−E[Q0(X,A)|X].(3.2)
T0(x,a) is the centered effect of treatment A = a at observation X = x;
d0(X) ∈ argmaxa T0(X,a).
Theorem 3.1. Suppose p(a|x) ≥ S−1 for a positive constant S for all
(x,a) pairs. Assume there exists some constants C > 0 and α≥ 0 such that
P
(
max
a∈A
T0(X,a)− max
a∈A\argmaxa∈A T0(X,a)
T0(X,a)≤ ǫ
)
≤Cǫα(3.3)
for all positive ǫ. Then for any ITR d :X →A and square integrable function
Q :X ×A→R such that d(X) ∈ argmaxa∈AQ(X,a) a.s., we have
V (d0)− V (d)≤C ′[L(Q)−L(Q0)](1+α)/(2+α)(3.4)
and
V (d0)− V (d)≤C ′[E(T (X,A)− T0(X,A))2](1+α)/(2+α),(3.5)
where C ′ = (22+3αS1+αC)1/(2+α).
The proof of Theorem 3.1 is in Appendix A.1.
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Remarks.
(1) We set the second maximum in (3.3) to −∞ if for an x, T0(x,a) is
constant in a and thus the set A\ argmaxa∈A T0(x,a) =∅.
(2) Condition (3.3) is similar to the margin condition in classification
[18, 24, 32]; in classification this assumption is often used to obtain sharp
upper bounds on the excess 0–1 risk in terms of other surrogate risks [2].
Here maxa∈A T0(x,a) − maxa∈A\argmaxa∈A T0(x,a) T0(x,a) can be viewed as
the “margin” of T0 at observation X = x. It measures the difference in mean
responses between the optimal treatment(s) and the best suboptimal treat-
ment(s) at x. For example, suppose X ∼ U [−1,1], P (A = 1|X) = P (A =
−1|X) = 1/2 and T0(X,A) = XA. Then the margin condition holds with
C = 1/2 and α = 1. Note the margin condition does not exclude multiple
optimal treatments for any observation x. However, when α > 0, it does
exclude suboptimal treatments that yield a conditional mean response very
close to the largest conditional mean response for a set of x with nonzero
probability.
(3) For C = 1, α = 0, condition (3.3) always holds for all ǫ > 0; in this
case (3.4) reduces to (3.1).
(4) The larger the α, the larger the exponent (1+α)/(2+α) and thus the
stronger the upper bounds in (3.4) and (3.5). However, the margin condition
is unlikely to hold for all ǫ if α is very large. An alternate margin condition
and upper bound are as follows.
Suppose p(a|x)≥ S−1 for all (x,a) pairs. Assume there is an ǫ>0, such that
P
(
max
a∈A
T0(X,a)− max
a∈A\argmaxa∈A T0(X,a)
T0(X,a)< ǫ
)
= 0.(3.6)
Then V (d0) − V (d) ≤ 4S[L(Q) − L(Q0)]/ǫ and V (d0) − V (d) ≤ 4SE(T −
T0)
2/ǫ.
The proof is essentially the same as that of Theorem 3.1 and is omitted.
Condition (3.6) means that T0 evaluated at the optimal treatment(s) mi-
nus T0 evaluated at the best suboptimal treatment(s) is bounded below by
a positive constant for almost all X observations. If X assumes only a finite
number of values, then this condition always holds, because we can take ǫ to
be the smallest difference in T0 when evaluated at the optimal treatment(s)
and the suboptimal treatment(s) [note that if T0(x,a) is constant for all
a ∈A for some observation X = x, then all treatments are optimal for that
observation].
(5) Inequality (3.5) cannot be improved in the sense that choosing T =
T0 yields zero on both sides of the inequality. Moreover, an inequality in
the opposite direction is not possible, since each ITR is associated with
many nontrivial T -functions. For example, suppose X ∼ U [−1,1], P (A =
1|X) = P (A=−1|X) = 1/2 and T0(X,A) = (X − 1/3)2A. The optimal ITR
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is d0(X) = 1 a.s. Consider T (X,A) = θA. Then maximizing T (X,A) yields
the optimal ITR as long as θ > 0. This means that the left-hand side (LHS)
of (3.5) is zero, while the right-hand side (RHS) is always positive no matter
what value θ takes.
Theorem 3.1 supports the approach of minimizing the estimated predic-
tion error to estimate Q0 or T0 and then maximizing this estimator over
a ∈A to obtain an ITR. It is natural to expect that even when the approx-
imation space used in estimating Q0 or T0 does not contain the truth, this
approach will provide the best (highest Value) of the considered ITRs. Unfor-
tunately, this does not occur due to the mismatch between the loss functions
(weighted 0–1 loss and the quadratic loss). This mismatch is indicated by
remark (5) above. More precisely, note that the approximation space, say Q
for Q0, places implicit restrictions on the class of ITRs that will be consid-
ered. In effect, the class of ITRs is DQ = {d(X) ∈ argmaxaQ(X,a) :Q ∈Q}.
It turns out that minimizing the prediction error may not result in the ITR
in DQ that maximizes the Value. This occurs when the approximation space
Q does not provide a treatment effect term close to the treatment effect term
in Q0. In the following toy example, the optimal ITR d0 belongs to DQ, yet
the prediction error minimizer over Q does not yield d0.
A toy example. Suppose X is uniformly distributed in [−1,1], A is
binary {−1,1} with probability 1/2 each and is independent of X , and R
is normally distributed with mean Q0(X,A) = (X − 1/3)2A and variance 1.
It is easy to see that the optimal ITR satisfies d0(X) = 1 a.s. and V (d0) =
4/9. Consider approximation space Q = {Q(X,A;θ) = (1,X,A,XA)θ :θ ∈
R
4} for Q0. Thus the space of ITRs under consideration is DQ = {d(X) =
sign(θ3 + θ4X) : θ3, θ4 ∈ R}. Note that d0 ∈ DQ since d0(X) can be writ-
ten as sign(θ3 + θ4X) for any θ3 > 0 and θ4 = 0. d0 is the best treat-
ment rule in DQ. However, minimizing the prediction error L(Q) over Q
yields Q∗(X,A) = (4/9− 2/3X)A. The ITR associated with Q∗ is d∗(X) =
argmaxa∈{−1,1}Q
∗(X,a) = sign(2/3 −X), which has lower Value than d0
(V (d∗) =E[
1A(2/3−X)>0R
1/2 ] = 29/81< V (d0)).
4. Estimation via l1-penalized least squares. To deal with the mismatch
between minimizing the prediction error and maximizing the Value discussed
in the prior section, we consider a large linear approximation space Q for Q0.
Since overfitting is likely (due to the potentially large number of pretreat-
ment variables and/or large approximation space for Q0), we use penalized
least squares (see Section S.1 of the supplemental article [25] for further dis-
cussion of the overfitting problem). Furthermore, we use l1-penalized least
squares (l1-PLS, [31]) as the l1 penalty does some variable selection and as
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a result will lead to ITRs that are cheaper to implement (fewer variables to
collect per patient) and easier to interpret. See Section 6 for the discussion
of other potential penalization methods.
Let {(Xi,Ai,Ri)}ni=1 represent i.i.d. observations on n subjects in a ran-
domized trial. For convenience, we use En to denote the associated empirical
expectation [i.e., Enf =
∑n
i=1 f(Xi,Ai,Ri)/n for any real-valued function f
on X ×A × R]. Let Q , {Q(X,A;θ) = Φ(X,A)θ,θ ∈ RJ} be the approxi-
mation space for Q0, where Φ(X,A) = (φ1(X,A), . . . , φJ(X,A)) is a 1 by J
vector composed of basis functions on X ×A, θ is a J by 1 parameter vector,
and J is the number of basis functions (for clarity here J will be fixed in n,
see Appendix A.2 for results with J increasing as n increases). The l1-PLS
estimator of θ is
θˆn = argmin
θ∈RJ
{
En[R−Φ(X,A)θ]2 + λn
J∑
j=1
σˆj|θj|
}
,(4.1)
where σˆj = [Enφj(X,A)
2]1/2, θj is the jth component of θ and λn is a tuning
parameter that controls the amount of penalization. The weights σˆj ’s are
used to balance the scale of different basis functions; these weights were
used in Bunea, Tsybakov and Wegkamp [4] and van de Geer [33]. In some
situations, it is natural to penalize only a subset of coefficients and/or use
different weights in the penalty; see Section S.2 of the supplemental artic-
le [25] for required modifications. The resulting estimated ITR satisfies
dˆn(X) ∈ argmax
a∈A
Φ(X,a)θˆn.(4.2)
4.1. Performance guarantee for the l1-PLS. In this section, we provide
finite sample upper bounds on the difference between the optimal Value and
the Value obtained by the l1-PLS estimator in terms of the prediction errors
resulting from the estimation of Q0 and T0. These upper bounds guarantee
that if Q0 (or T0) is consistently estimated, the Value of the estimated
ITR will converge to the optimal Value. Perhaps more importantly, the
finite sample upper bounds provided below do not require the assumption
that either Q0 or T0 is consistently estimated. Thus, each upper bound
includes approximation error as well as estimation error. The estimation
error decreases with decreasing model sparsity and increasing sample size.
An “oracle” model for Q0 (or T0) minimizes the sum of these two errors
among suitably sparse linear models [see remark (2) after Theorem 4.3 for
a precise definition of the oracle model]. In finite samples, the upper bounds
imply that dˆn, the ITR produced by the l1-PLS method, will have Value
roughly as if the l1-PLS method detects the sparsity of the oracle model
and then estimates from the oracle model using ordinary least squares [see
remark (3) below].
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Define the prediction error minimizer θ∗ ∈RJ by
θ
∗ ∈ argmin
θ∈RJ
L(Φθ) = argmin
θ∈RJ
E(R−Φθ)2.(4.3)
For expositional simplicity assume that θ∗ is unique, and define the spar-
sity of θ ∈ RJ by its l0 norm, ‖θ‖0 (see Appendix A.2 for a more general
setting, where θ∗ is not unique and a laxer definition of sparsity is used).
As discussed above, for finite n, instead of estimating θ∗, the l1-PLS es-
timator θˆn estimates a parameter θ
∗∗
n , possessing small prediction error
and with controlled sparsity. For any bounded function f on X × A, let
‖f‖∞ , supx∈X ,a∈A |f(x,a)|. θ∗∗n lies in the set of parameters Θn defined
by
Θn ,
{
θ ∈RJ :‖Φ(θ− θ∗)‖∞ ≤ η,
max
j=1,...,J
∣∣∣∣E[φjΦ(θ− θ∗)]σj
∣∣∣∣≤ 11η
√
log(Jn)
n
(4.4)
and ‖θ‖0 ≤ β
489U
√
n
log(Jn)
}
,
where σj = (Eφ
2
j )
1/2, and η, β and U are positive constants that will be
defined in Theorem 4.1.
The first two conditions in (4.4) restrict Θn to θ’s with controlled distance
in sup norm and with controlled distance in prediction error via first order
derivatives (note that |E[φjΦ(θ− θ∗)]/σj |= |∂L(Φθ)/∂θj − ∂L(Φθ∗)/∂θ∗j |/
2σj). The third condition restricts Θn to sparse θ’s. Note that as n in-
creases this sparsity requirement becomes laxer, ensuring that θ∗ ∈ Θn for
sufficiently large n.
When Θn is nonempty, θ
∗∗
n is given by
θ
∗∗
n = argmin
θ∈Θn
[L(Φθ) + 3‖θ‖0λ2n/β].(4.5)
Note that θ∗∗n is at least as sparse as θ
∗ since by (4.3), L(Φθ)+3‖θ‖0λ2n/β >
L(Φθ∗) + 3‖θ∗‖0λ2n/β for any θ such that ‖θ‖0 > ‖θ∗‖0.
The following theorem provides a finite sample performance guarantee for
the ITR produced by the l1-PLS method. Intuitively, this result implies that
if Q0 can be well approximated by the sparse linear representation θ
∗∗
n [so
that both L(Φθ∗∗n )− L(Q0) and ‖θ∗∗n ‖0 are small], then dˆn will have Value
close to the optimal Value in finite samples.
Theorem 4.1. Suppose p(a|x) ≥ S−1 for a positive constant S for all
(x,a) pairs and the margin condition (3.3) holds for some C > 0, α≥ 0 and
all positive ǫ. Assume:
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(1) the error terms εi =Ri −Q0(Xi,Ai), i= 1, . . . , n, are independent of
(Xi,Ai), i = 1, . . . , n and are i.i.d. with E(εi) = 0 and E[|εi|l] ≤ l!cl−2σ2/2
for some c, σ2 > 0 for all l≥ 2;
(2) there exist finite, positive constants U and η such that maxj=1,...,J
‖φj‖∞/σj ≤ U and ‖Q0 −Φθ∗‖∞ ≤ η; and
(3) E[(φ1/σ1, . . . , φJ/σJ)
T (φ1/σ1, . . . , φJ/σJ)] is positive definite, and the
smallest eigenvalue is denoted by β.
Consider the estimated ITR dˆn defined by (4.2) with tuning parameter
λn ≥ k
√
log(Jn)
n
,(4.6)
where k = 82max{c, σ, η}. Let Θn be the set defined in (4.4). Then for any
n≥ 24U2 log(Jn) and for which Θn is nonempty, we have, with probability
at least 1− 1/n, that
V (d0)− V (dˆn)≤C ′
[
min
θ∈Θn
(L(Φθ)−L(Q0) + 3‖θ‖0λ2n/β)
](1+α)/(2+α)
,(4.7)
where C ′ = (22+3αS1+αC)1/(2+α).
The result follows from inequality (3.4) in Theorem 3.1 and inequality
(4.10) in Theorem 4.3. Similar results in a more general setting can be
obtained by combining (3.4) with inequality (A.7) in Appendix A.2.
Remarks.
(1) Note that θ∗∗n is the minimizer of the upper bound on the RHS of
(4.7) and that θ∗∗n is contained in the set {θ∗,(m)n :m ⊂ {1, . . . , J}}. Each
θ
∗,(m)
n satisfies θ
∗,(m)
n = argmin{θ∈Θn : θj=0 for all j /∈m}L(Φθ); that is, θ
∗,(m)
n
minimizes the prediction error of the model indexed by the set m (i.e.,
model {∑j∈mφjθj : θj ∈R}) (within Θn). For each θ∗,(m)n , the first term in
the upper bound in (4.7) [i.e., L(Φθ
∗,(m)
n ) − L(Q0)] is the approximation
error of the model indexed by m within Θn. As in van de Geer [33], we call
the second term 3‖θ∗,(m)n ‖0λ2n/β the estimation error of the model indexed
by m. To see why, first put λn = k
√
log(Jn)/n. Then, ignoring the log(n)
factor, the second term is a function of the sparsity of model m relative
to the sample size, n. Up to constants, the second term is a “tight” upper
bound for the estimation error of the OLS estimator from model m, where
“tight” means that the convergence rate in the bound is the best known rate.
Note that θ∗∗n is the parameter that minimizes the sum of the two errors
over all models. Such a model (the model corresponding to θ∗∗n ) is called an
oracle model. The log(n) factor in the estimation error can be viewed as the
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price paid for not knowing the sparsity of the oracle model and thus having
to conduct model selection. See remark (2) after Theorem 4.3 for the precise
definition of the oracle model and its relationship to θ∗∗n .
(2) Suppose λn = o(1). Then in large samples the estimation error term
3‖θ‖0λ2n/β is negligible. In this case, θ∗∗n is close to θ∗. When the model
Φθ∗ approximates Q0 sufficiently well, we see that setting λn equal to its
lower bound in (4.6) provides the fastest rate of convergence of the upper
bound to zero. More precisely, suppose Q0 =Φθ
∗ [i.e., L(Φθ∗)−L(Q0) = 0].
Then inequality (4.7) implies that V (d0)−V (dˆn)≤Op((logn/n)(1+α)/(2+α)).
A convergence in mean result is presented in Corollary 4.1.
(3) In finite samples, the estimation error 3‖θ‖0λ2n/β is nonnegligible.
The argument of the minimum in the upper bound (4.7), θ∗∗n , minimizes
prediction error among parameters with controlled sparsity. In remark (2)
after Theorem 4.3, we discuss how this upper bound can be viewed as a tight
upper bound for the prediction error of the OLS estimator from an oracle
model in the step-wise model selection setting. In this sense, inequality (4.7)
implies that the treatment rule produced by the l1-PLS method will have
a reduction in Value roughly as if it knew the sparsity of the oracle model
and were estimated from the oracle model using OLS.
(4) Assumptions (1)–(3) in Theorem 4.1 are employed to derive the finite
sample prediction error bound for the l1-PLS estimator θˆn defined in (4.1).
Below we briefly discuss these assumptions.
Assumption (1) implicitly implies that the error terms do not have heavy
tails. This condition is often assumed to show that the sample mean of
a variable is concentrated around its true mean with a high probability. It is
easy to verify that this assumption holds if each εi is bounded. Moreover, it
also holds for some commonly used error distributions that have unbounded
support, such as the normal or double exponential.
Assumption (2) is also used to show the concentration of the sample mean
around the true mean. It is possible to replace the boundedness condition
by a moment condition similar to assumption (1). This assumption requires
that all basis functions and the difference between Q0 and its best linear
approximation are bounded. Note that we do not assume Q to be a good
approximation space for Q0. However, if Φθ
∗ approximates Q0 well, η will
be small, which will result in a smaller upper bound in (4.7). In fact, in the
generalized result (Theorem A.1) we allow U and η to increase in n.
Assumption (3) is employed to avoid collinearity. In fact, we only need
E[Φ(θ′ − θ)]2‖θ‖0 ≥ β
( ∑
j∈M0(θ)
σj |θ′j − θj|
)2
(4.8)
for θ, θ′ belonging to a subset of RJ (see Assumption A.3), where M0(θ),
{j = 1, . . . , J : θj 6= 0}. Condition (4.8) has been used in van de Geer [33]. This
12 M. QIAN AND S. A. MURPHY
condition is also similar to the restricted eigenvalue assumption in Bickel,
Ritov and Tsybakov [3] in which E is replaced by En, and a fixed design ma-
trix is considered. Clearly, assumption (3) is a sufficient condition for (4.8).
In addition, condition (4.8) is satisfied if the correlation |Eφjφk|/(σjσk) is
small for all k ∈M0(θ), j 6= k and a subset of θ’s (similar results in a fixed
design setting have been proved in Bickel, Ritov and Tsybakov [3]. The
condition on correlation is also known as “mutual coherence” condition in
Bunea, Tsybakov and Wegkamp [4]). See Bickel, Ritov and Tsybakov [3] for
other sufficient conditions for (4.8).
The above upper bound for V (d0)−V (dˆn) involves L(Φθ)−L(Q0), which
measures how well the conditional mean function Q0 is approximated by Q.
As we have seen in Section 3, the quality of the estimated ITR only de-
pends on the estimator of the treatment effect term T0. Below we provide
a strengthened result in the sense that the upper bound depends only on
how well we approximate the treatment effect term.
First, we identify terms in the linear model Q that approximate T0 (re-
call that T0(X,A),Q0(X,A)−E[Q0(X,A)|X]). Without loss of generality,
we rewrite the vector of basis functions as Φ(X,A) = (Φ(1)(X),Φ(2)(X,A)),
where Φ(1) = (φ1(X), . . . , φJ(1)(X)) is composed of all components in Φ that
do not contain A and Φ(2) = (φJ(1)+1(X,A), . . . , φJ(X,A)) is composed of all
components in Φ that contain A. Note that A takes only finite values. When
the randomization distribution p(a|x) does not depend on x, we can code A
so that E[Φ(2)(X,A)T |X] = 0 a.s. (see Section 5.2 and Appendix A.3, for
examples). For any θ= (θ1, . . . , θJ)
T ∈RJ , denote θ(1) = (θ1, . . . , θJ(1))T and
θ
(2) = (θJ(1)+1, . . . , θJ)
T . Then Φ(1)θ(1) approximates E[Q0(X,A)|X] and
Φ(2)θ(2) approximates T0.
The following theorem implies that if the treatment effect term T0 can be
well approximated by a sparse representation, then dˆn will have Value close
to the optimal Value.
Theorem 4.2. Suppose p(a|x) ≥ S−1 for a positive constant S for all
(x,a) pairs and the margin condition (3.3) holds for some C > 0, α ≥ 0
and all positive ǫ. Assume E[Φ(2)(X,A)T |X] = 0 a.s. Suppose assumptions
(1)–(3) in Theorem 4.1 hold. Let dˆn be the estimated ITR with λn sat-
isfying condition (4.6). Let Θn be the set defined in (4.4). Then for any
n≥ 24U2 log(Jn) and for which Θn is nonempty, we have, with probability
at least 1− 1/n, that
V (d0)− V (dˆn)
(4.9)
≤C ′
[
min
θ∈Θn
(E(Φ(2)θ(2) − T0)2 +5‖θ(2)‖0λ2n/β)
](1+α)/(2+α)
,
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where C ′ = (22+3αS1+αC)1/(2+α).
The result follows from inequality (3.5) in Theorem 3.1 and inequality
(4.11) in Theorem 4.3.
Remarks.
(1) Inequality (4.9) improves inequality (4.7) in the sense that it guar-
antees a small reduction in Value of dˆn [i.e., V (d0)− V (dˆn)] as long as the
treatment effect term T0 is well approximated by a sparse linear represen-
tation; it does not require a good approximation of the entire conditional
mean function Q0. In many situations Q0 may be very complex, but T0
could be very simple. This means that T0 is much more likely to be well
approximated as compared to Q0 (indeed, if there is no difference between
treatments, then T0 ≡ 0).
(2) Inequality (4.9) cannot be improved in the sense that if there is no
treatment effect (i.e., T0 ≡ 0), then both sides of the inequality are zero.
This result implies that minimizing the penalized empirical prediction error
indeed yields high Value (at least asymptotically) if T0 can be well approx-
imated.
The following asymptotic result follows from Theorem 4.2. Note that
when E[Φ(2)(X,A)T |X] = 0 a.s., L(Φθ)−L(Q0) =E[Φ(1)θ(1)−E(Q0|X)]2+
E[Φ(2)θ(2) − T0]2. Thus, the estimation of the treatment effect term T0
is asymptotically separated from the estimation of the main effect term
E(Q0|X). In this case, Φ(2)θ(2),∗ is the best linear approximation of the
treatment effect term T0, where θ
(2),∗ is the vector of components in θ∗
corresponding to Φ(2).
Corollary 4.1. Suppose p(a|x) ≥ S−1 for a positive constant S for
all (x,a) pairs and the margin condition (3.3) holds for some C > 0, α≥ 0
and all positive ǫ. Assume E[Φ(2)(X,A)T |X] = 0 a.s. In addition, suppose
assumptions (1)–(3) in Theorem 4.1 hold. Let dˆn be the estimated ITR with
tuning parameter λn = k1
√
log(Jn)/n for a constant k1 ≥ 82max{c, σ, η}. If
T0(X,A) = Φ
(2)
θ
(2),∗, then
V (d0)−E[V (dˆn)] =O((logn/n)(1+α)/(2+α)).
This result provides a guarantee on the convergence rate of V (dˆn) to the
optimal Value. More specifically, it means that if T0 is correctly approxi-
mated, then the Value of dˆn will converge to the optimal Value in mean at
rate at least as fast as (logn/n)(1+α)/(2+α) with an appropriate choice of λn.
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4.2. Prediction error bound for the l1-PLS estimator. In this section, we
provide a finite sample upper bound for the prediction error of the l1-PLS
estimator θˆn. This result is needed to prove Theorem 4.1. Furthermore, this
result strengthens existing literature on l1-PLS method in prediction. Fi-
nite sample prediction error bounds for the l1-PLS estimator in the random
design setting have been provided in Bunea, Tsybakov and Wegkamp [4]
for quadratic loss, van de Geer [33] mainly for Lipschitz loss, and Koltchin-
skii [15] for a variety of loss functions. With regards quadratic loss, Koltchin-
skii [15] requires the response Y is bounded, while both Bunea, Tsybakov
and Wegkamp [4] and van de Geer [33] assumed the existence of a sparse
θ ∈ RJ such that E(Φθ − Q0)2 is upper bounded by a quantity that de-
creases to 0 at a certain rate as n→∞ (by permitting J to increase with
n so Φ depends on n as well). We improve the results in the sense that we
do not make such assumptions (see Appendix A.2 for results when Φ, J are
indexed by n and J increases with n).
As in the prior sections, the sparsity of θ is measured by its l0 norm,
‖θ‖0 (see the Appendix A.2 for proofs with a laxer definition of sparsity).
Recall that the parameter θ∗∗n defined in (4.5) has small prediction error and
controlled sparsity.
Theorem 4.3. Suppose assumptions (1)–(3) in Theorem 4.1 hold. For
any η1 ≥ 0, let θˆn be the l1-PLS estimator defined by (4.1) with tuning
parameter λn satisfying condition (4.6). Let Θn be the set defined in (4.4).
Then for any n ≥ 24U2 log(Jn) and for which Θn is nonempty, we have,
with probability at least 1− 1/n, that
L(Φθˆn)≤ min
θ∈Θn
(L(Φθ) + 3‖θ‖0λ2n/β) = L(Φθ∗∗n ) + 3‖θ∗∗n ‖0λ2n/β.(4.10)
Furthermore, suppose E[Φ(2)(X,A)T |X] = 0 a.s. Then with probability at
least 1− 1/n,
E(Φ(2)θˆ(2)n − T0)2 ≤ min
θ∈Θn
(E(Φ(2)θ(2) − T0)2 +5‖θ(2)‖0λ2n/β).(4.11)
The results follow from Theorem A.1 in Appendix A.2 with ρ= 0, γ = 1/8,
η1 = η2 = η, t= log 2n and some simple algebra [notice that assumption (3)
in Theorem 4.1 is a sufficient condition for Assumptions A.3 and A.4].
Remarks. Inequality (4.11) provides a finite sample upper bound on
the mean square difference between T0 and its estimator. This result is used
to prove Theorem 4.2. The remarks below discuss how inequality (4.10)
contributes to the l1-penalization literature in prediction.
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(1) The conclusion of Theorem 4.3 holds for all choices of λn that sat-
isfy (4.6). Suppose λn = o(1). Then L(Φθ
∗∗
n )−L(Φθ∗)→ 0 as n→∞ (since
‖θ‖0 is bounded). Inequality (4.10) implies that L(Φθˆn) − L(Φθ∗)→ 0 in
probability. To achieve the best rate of convergence, equal sign should be
taken in (4.6).
(2) Note that θ∗∗n minimizes L(Φθ)−L(Q0) + 3‖θ‖0λ2n/β. Below we de-
monstrate that the minimum of L(Φθ)−L(Q0)+ 3‖θ‖0λ2n/β can be viewed
as the approximation error plus a “tight” upper bound of the estimation
error of an “oracle” in the stepwise model selection framework [when “=”
is taken in (4.6)]. Here “tight” means the convergence rate in the bound is
the best known rate, and “oracle” is defined as follows.
Let m denote a nonempty subset of the index set {1, . . . , J}. Then each m
represents a model which uses a nonempty subset of {φ1, . . . , φJ} as basis
functions (there are 2J − 1 such subsets). Define
θˆ
(m)
n = argmin
{θ∈RJ : θj=0 for all j /∈m}
En(R−Φθ)2
and
θ
∗,(m) = argmin
{θ∈RJ : θj=0 for all j /∈m}
L(Φθ).
In this setting, an ideal model selection criterion will pick modelm∗ such that
L(Φθˆ
(m∗)
n ) = infmL(Φθˆ
(m)
n ). θˆ
(m∗)
n is referred as an “oracle” in Massart [19].
Note that the excess prediction error of each θˆ
(m)
n can be written as
L(Φθˆ(m)n )−L(Q0) = [L(Φθ∗,(m))−L(Q0)] + [L(Φθˆ(m)n )−L(Φθ∗,(m))],
where the first term is called the approximation error of model m and the
second term is the estimation error. It can be shown that [1] for each model
m and xm > 0, with probability at least 1− exp(−xm),
L(Φθˆ(m)n )−L(Φθ∗,(m))≤ constant×
(
xm + |m| log(n/|m|)
n
)
under appropriate technical conditions, where |m| is the cardinality of the
index set m. To our knowledge, this is the best rate known so far. Taking
xm = logn+ |m| logJ and using the union bound argument, we have with
probability at least 1−O(1/n),
L(Φnθˆ
(m∗)
n )−L(Q0)
= min
m
([L(Φθ∗,(m))−L(Q0)] +L(Φθˆ(m)n )−L(Φθ∗,(m)))
≤min
m
(
[L(Φθ∗,(m))−L(Q0)] + constant× |m| log(Jn)
n
)
=min
θ
(
[L(Φθ)−L(Q0)] + constant× ‖θ‖0 log(Jn)
n
)
.(4.12)
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On the other hand, take λn so that condition (4.6) holds with “=”. Equa-
tion (4.10) implies that, with probability at least 1− 1/n,
L(Φθˆn)−L(Q0)≤ min
θ∈Θn
(
[L(Φθ)−L(Q0)] + constant× ‖θ‖0 log(Jn)
n
)
,
which is essentially (4.12) with the constraint of θ ∈Θn. (The “constant” in
the above inequalities may take different values.) Since θ = θ∗∗n minimizes
the approximation error plus a tight upper bound for the estimation error
in the oracle model, within θ ∈Θn, we refer to θ∗∗n as an oracle.
(3) The result can be used to emphasize that l1 penalty behaves sim-
ilarly as the l0 penalty. Note that θˆn minimizes the empirical prediction
error En(R−Φθ)2 plus an l1 penalty, whereas θ∗∗n minimizes the prediction
error L(Φθ) plus an l0 penalty. We provide an intuitive connection between
these two quantities. First, note that En(R−Φθ)2 estimates L(Φθ) and σˆj
estimates σj . We use “≈” to denote this relationship. Thus,
En(R−Φθ)2 + λn
J∑
j=1
σˆj|θj |(4.13)
≈ L(Φθ) + λn
J∑
j=1
σj|θj |
≤ L(Φθ) + λn
J∑
j=1
σj|θˆn,j − θj|+ λn
J∑
j=1
σj |θˆn,j|,
where θˆn,j is the jth component of θˆn. In Appendix A.2, we show that
for any θ ∈ Θn, λn
∑J
j=1 σj|θˆn,j − θj| is upper bounded by ‖θ‖0λ2n/β up
to a constant with a high probability. Thus, θˆn minimizes (4.13) and θ
∗∗
n
roughly minimizes an upper bound of (4.13).
(4) The constants involved in the theorem can be improved; we focused
on readability as opposed to providing the best constants.
5. A practical implementation and an evaluation. In this section, we
develop a practical implementation of the l1-PLS method, compare this
method to two commonly used alternatives and lastly illustrate the method
using the motivating data from the Nefazodone-CBASP trial [13].
A realistic implementation of l1-PLS method should use a data-dependent
method to select the tuning parameter, λn. Since the primary goal is to max-
imize the Value, we select λn to maximize a cross validated Value estimator.
For any ITR d, it is easy to verify that E[(R− V (d))1A=d(X)/p(A|X)] = 0.
Thus, an unbiased estimator of V (d) is
En[1A=d(X)R/p(A|X)]/En[1A=d(X)/p(A|X)]
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[22] [recall that the randomization distribution p(a|X) is known]. We split
the data into 10 roughly equal-sized parts; then for each λn we apply the
l1-PLS based method on each 9 parts of the data to obtain an ITR, and
estimate the Value of this ITR using the remaining part; the λn that max-
imizes the average of the 10 estimated Values is selected. Since the Value
of an ITR is noncontinuous in the parameters, this usually results in a set
of candidate λn’s achieving maximal Value. In the simulations below, the
resulting λn is nonunique in around 97% of the data sets. If necessary, as
a second step we reduce the set of λn’s by including only λn’s leading to
the ITR’s using the least number of variables. In the simulations below, this
second criterion effectively reduced the number of candidate λn’s in around
25% of the data sets, however multiple λn’s still remained in around 90%
of the data sets. This is not surprising since the Value of an ITR only de-
pends on the relative magnitudes of parameters in the ITR. In the third
step we select the λn that minimizes the 10-fold cross validated prediction
error estimator from the remaining candidate λn’s; that is, minimization of
the empirical prediction error is used as a final tie breaker.
5.1. Simulations. A first alternative to l1-PLS is to use ordinary least
squares (OLS). The estimated ITR is dˆOLS ∈ argmaxaΦ(X,a)θˆOLS where
θˆOLS is the OLS estimator of θ. A second alternative is called “progno-
sis prediction” [14]. Usually this method employs multiple data sets, each of
which involves one active treatment. Then the treatment associated with the
best predicted prognosis is selected. We implement this method by estimat-
ing E(R|X,A= a) via least squares with l1 penalization for each treatment
group (each a ∈A) separately. The tuning parameter involved in each treat-
ment group is selected by minimizing the 10-fold cross-validated prediction
error estimator. The resulting ITR satisfies dˆPP(X) ∈ argmaxa∈A Eˆ(R|X,A=
a) where the subscript “PP” denotes prognosis prediction.
For simplicity, we consider binary A. All three methods use the same
number of data points and the same number of basis functions but use these
data points/basis functions differently. l1-PLS and OLS use all J basis func-
tions to conduct estimation with all n data points whereas the prognosis
prediction method splits the data into the two treatment groups and uses
J/2 basis functions to conduct estimation with the n/2 data points in each
of the two treatment groups. To ensure the comparison is fair across the
three methods, the approximation model for each treatment group is con-
sistent with the approximation model used in both l1-PLS and OLS [e.g., if
Q0 is approximated by (1,X,A,XA)θ in l1-PLS and OLS, then in prognosis
prediction we approximate E(R|X,A= a) by (1,X)θPP for each treatment
group]. We do not penalize the intercept coefficient in either prognosis pre-
diction or l1-PLS.
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The three methods are compared using two criteria: (1) Value maximiza-
tion; and (2) simplicity of the estimated ITRs (measured by the number of
variables/basis functions used in the rule).
We illustrate the comparison of the three methods using 4 examples se-
lected to reflect three scenarios (see Section S.3 of the supplemental article
[25] for 4 further examples):
(1) There is no treatment effect [i.e., Q0 is constructed so that T0 = 0;
example (1)]. In this case, all ITRs yield the same Value. Thus, the simplest
rule is preferred.
(2) There is a treatment effect and the treatment effect term T0 is cor-
rectly modeled [example (4) for large n and example (2)]. In this case, min-
imizing the prediction error will yield the ITR that maximizes the Value.
(3) There is a treatment effect and the treatment effect term T0 is mis-
specified [example (4) for small n and example (3)]. In this case, there might
be a mismatch between prediction error minimization and Value maximiza-
tion.
The examples are generated as follows. The treatment A is generated
uniformly from {−1,1} independent of X and the response R. The response
R is normally distributed with mean Q0(X,A). In examples (1)–(3), X ∼
U [−1,1]5 and we consider three simple examples for Q0. In example (4),
X ∼ U [0,1] and we use a complex Q0, where Q0(X,1) and Q(X,−1) are
similar to the blocks function used in Donoho and Johnstone [8]. Further
details of the simulation design are provided in Appendix A.3.
We consider two types of approximation models for Q0. In examples (1)–
(3), we approximate Q0 by (1,X,A,XA)θ. In example (4), we approximate
Q0 by Haar wavelets. The number of basis functions may increase as n
increases (we index J , Φ and θ∗ by n in this case). Plots for Q0(X,A) and
the associated best wavelet fits Φn(X,A)θ
∗
n are provided in Figure 1.
For each example, we simulate data sets of sizes n= 2k for k = 5, . . . ,10.
1,000 data sets are generated for each sample size. The Value of each esti-
mated ITR is evaluated via Monte Carlo using a test set of size 10,000. The
Value of the optimal ITR is also evaluated using the test set.
Simulation results are presented in Figure 2. When the approximation
model is of high quality, all methods produce ITRs with similar Value [see
examples (1), (2) and example (4) for large n]. However, when the approx-
imation model is poor, the l1-PLS method may produce highest Value [see
example (3)]. Note that in example (3) settings in which the sample size is
small, the Value of the ITR produced by l1-PLS method has larger median
absolute deviation (MAD) than the other two methods. One possible reason
is that due to the mismatch between maximizing the Value and minimizing
the prediction error, the Value estimator plays a strong role in selecting λn.
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Fig. 1. Plots for: the conditional mean function Q0(X,A) ( left), Q0(X,A) and the asso-
ciated best wavelet fit when Jn = 8 (middle), and Q0(X,A) and the associated best wavelet
fit when Jn = 128 ( right) [example (4)].
The nonsmoothness of the Value estimator combined with the mismatch re-
sults in very different λn’s and thus the estimated decision rules vary greatly
from data set to data set in this example. Nonetheless, the l1-PLS method
is still preferred after taking the variation into account; indeed l1-PLS pro-
duces ITRs with higher Value than both OLS and PP in around 46%, 55%
and 67% in data sets of sizes n= 32,64 and 128, respectively. Furthermore,
in general the l1-PLS method uses much fewer variables for treatment as-
signment than the other two methods. This is expected because the OLS
method does not have variable selection functionality and the PP method
will use all variables that are predictive of the response R whereas the use
of the Value in selecting the tuning parameter in l1-PLS discounts variables
that are only useful in predicting the response (and less useful in selecting
the best treatment).
5.2. Nefazodone-CBASP trial example. The Nefazodone-CBASP trial
was conducted to compare the efficacy of several alternate treatments for
patients with chronic depression. The study randomized 681 patients with
nonpsychotic chronic major depressive disorder (MDD) to either Nefazodone,
cognitive behavioral-analysis system of psychotherapy (CBASP) or the com-
bination of the two treatments. Various assessments were taken throughout
the study, among which the score on the 24-item Hamilton Rating Scale
for Depression (HRSD) was the primary outcome. Low HRSD scores are
desirable. See Keller et al. [13] for more detail of the study design and the
primary analysis.
In the data analysis, we use a subset of the Nefazodone-CBASP data
consisting of 656 patients for whom the response HRSD score was observed.
In this trial, pairwise comparisons show that the combination treatment
resulted in significantly lower HRSD scores than either of the single treat-
ments. There was no overall difference between the single treatments.
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Fig. 2. Comparison of the l1-PLS based method with the OLS method and the PP method
[examples (1)–(4)]: plots for medians and median absolute deviations (MAD) of the Value
of the estimated decision rules (top panels) and the number of variables (terms) needed
for treatment assignment (including the main treatment effect term, bottom panels) over
1,000 samples versus sample size on the log scale. The black dash-dotted line in each
plot on the first row denotes the Value of the optimal treatment rule, for each example.
[n = 32,64,128,256,512,1024. The corresponding numbers of basis functions in example
(4) are Jn = 8,16,32,64,64,128.]
We use l1-PLS to develop an ITR. In the analysis, the HRSD score is re-
verse coded so that higher is better. We consider 50 pretreatment variables
X = (X1, . . . ,X50). Treatments are coded using contrast coding of dummy
variables A = (A1,A2), where A1 = 2 if the combination treatment is as-
signed and −1 otherwise and A2 = 1 if CBASP is assigned, −1 if nefa-
zodone and 0 otherwise. The vector of basis functions, Φ(X,A), is of the
form (1,X,A1,XA1,A2,XA2). So the number of basis functions is J = 153.
As a contrast, we also consider the OLS method and the PP method (sepa-
rate prognosis prediction for each treatment). The vector of basis functions
used in PP is (1,X) for each of the three treatment groups. Neither the
intercept term nor the main treatment effect terms in l1-PLS or PP is pe-
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nalized (see Section S.2 of the supplemental article [25] for the modification
of the weights σˆj used in (4.1)).
The ITR given by the l1-PLS method recommends the combination treat-
ment to all (so none of the pretreatment variables enter the rule). On the
other hand, the PP method produces an ITR that uses 29 variables. If the
rule produced by PP were used to assign treatment for the 656 patients in
the trial, it would recommend the combination treatment for 614 patients
and nefazodone for the other 42 patients. In addition, the OLS method will
use all the 50 variables. If the ITR produced by OLS were used to assign
treatment for the 656 patients in the trial, it would recommend the combi-
nation treatment for 429 patients, nefazodone for 145 patients and CBASP
for the other 82 patients.
6. Discussion. Our goal is to construct a high quality ITR that will
benefit future patients. We considered an l1-PLS based method and provided
a finite sample upper bound for V (d0)− V (dˆn), the reduction in Value of
the estimated ITR.
The use of an l1 penalty allows us to consider a large model for the
conditional mean function Q0 yet permits a sparse estimated ITR. In fact,
many other penalization methods such as SCAD [9] and l1 penalty with
adaptive weights (adaptive Lasso; [37]) also have this property. We choose
the nonadaptive l1 penalty to represent these methods. Interested readers
may justify other PLS methods using similar proof techniques.
The high probability finite sample upper bounds [i.e., (4.7) and (4.9)]
cannot be used to construct a prediction/confidence interval for V (d0) −
V (dˆn) due to the unknown quantities in the bound. How to develop a tight
computable upper bound to assess the quality of dˆn is an open question.
We used cross validation with Value maximization to select the tuning
parameter involved in the l1-PLS method. As compared to the OLS method
and the PP method, this method may yield higher Value when T0 is misspec-
ified. However, since only the Value is used to select the tuning parameter,
this method may produce a complex ITR for which the Value is only slightly
higher than that of a much simpler ITR. In this case, a simpler rule may
be preferred due to the interpretability and cost of collecting the variables.
Investigation of a tuning parameter selection criterion that trades off the
Value with the number of variables in an ITR is needed.
This paper studied a one stage decision problem. However, it is evident
that some diseases require time-varying treatment. For example, individu-
als with a chronic disease often experience a waxing and waning course of
illness. In these settings, the goal is to construct a sequence of ITRs that
tailor the type and dosage of treatment through time according to an indi-
vidual’s changing status. There is an abundance of statistical literature in
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this area [17, 20, 21, 27, 29, 30, 34, 35]. Extension of the least squares based
method to the multi-stage decision problem has been presented in Murphy
[21]. The performance of l1 penalization in this setting is unclear and worth
investigation.
APPENDIX
A.1. Proof of Theorem 3.1. For any ITR d :X → A, denote △Td(X)
,maxa∈A T0(X,a)− T0(X,d(X)). Using similar arguments to that in Sec-
tion 2, we have V (d0)−V (d) =E(△Td). If V (d0)−V (d) = 0, then (3.4) and
(3.5) automatically hold. Otherwise, E(△Td)2 ≥ (E△Td)2 > 0. In this case,
for any ǫ > 0, define the event
Ωǫ =
{
max
a∈A
T0(X,a)− max
a∈A\argmaxa∈A T0(X,a)
T0(X,a)≤ ǫ
}
.
Then △Td ≤ (△Td)2/ǫ on the event ΩCǫ . This together with the fact that
△Td ≤ (△Td)2/ǫ+ ǫ/4 implies
V (d0)− V (d) = E(1ΩCǫ △Td) +E(1Ωǫ△Td)
≤ 1
ǫ
E[1ΩCǫ (△Td)2] +E
[
1Ωǫ
(
(△Td)2
ǫ
+
ǫ
4
)]
=
1
ǫ
E[(△Td)2] + ǫ
4
P (Ωǫ)≤ 1
ǫ
E[(△Td)2] + C
4
ǫ1+α,
where the last inequality follows from the margin condition (3.3). Choosing
ǫ= (4E(△Td)2/C)1/(2+α) to minimize the above upper bound yields
V (d0)− V (d)≤ 2α/(2+α)C1/(2+α)[E(△Td)2](1+α)/(2+α) .(A.1)
Next, for any d and Q such that d(X) ∈maxa∈AQ(X,a), let T (X,A) be
the associated treatment effect term. Then
E(△Td)2 = E
[(
max
a∈A
T0(X,a)−max
a∈A
T (X,a) + T (X,d(X))− T0(X,d(X))
)2]
≤ 2E
[(
max
a∈A
T0(X,a)−max
a∈A
T (X,a)
)2
+ (T (X,d(X))− T0(X,d(X)))2
]
≤ 4E
[
max
a∈A
(T (X,a)− T0(X,a))2
]
,
where the last inequality follows from the fact that neither |maxa T0(X,a)−
maxa T (X,a)| nor |T (X,d(X))−T0(X,d(X))| is larger than maxa|T (X,a)−
T0(X,a)|. Since p(a|x)≥ S−1 for all (x,a) pairs, we have
E(△Td)2 ≤ 4SE
[∑
a∈A
(T (X,a)− T0(X,a))2p(a|X)
]
= 4SE(T (X,A)− T0(X,A))2.(A.2)
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Inequality (3.5) follows by substituting (A.2) into (A.1). Inequality (3.4)
can be proved similarly by noticing that △Td(X) = maxa∈AQ0(X,a) −
Q0(X,d(X)).
A.2. Generalization of Theorem 4.3. In this section, we present a gener-
alization of Theorem 4.3 where J may depend on n and the sparsity of any
θ ∈RJ is measured by the number of “large” components in θ as described
in Zhang and Huang [36]. In this case, J , Φ and the prediction error mini-
mizer θ∗ are denoted as Jn,Φn and θ
∗
n, respectively. All relevant quantities
and assumptions are restated below.
Let |M | denote the cardinality of any index set M ⊆ {1, . . . , Jn}. For any
θ ∈RJn and constant ρ≥ 0, define
Mρλn(θ) ∈ argmin
{M⊆{1,...,Jn} :
∑
j∈{1,...,Jn}\M
σj |θj |≤ρ|M |λn}
|M |.
Then Mρλn(θ) is the smallest index set that contains only “large” compo-
nents in θ. |Mρλn(θ)| measures the sparsity of θ. It is easy to see that when
ρ = 0, M0(θ) is the index set of nonzero components in θ and |M0(θ)| =
‖θ‖0. Moreover, Mρλn(θ) is an empty set if and only if θ = 0.
Let [θ∗n] be the set of most sparse prediction error minimizers in the linear
model, that is,
[θ∗n] = argmin
θ∈argminθ L(Φnθ)
|Mρλn(θ)|.(A.3)
Note that [θ∗n] depends on ρλn.
To derive the finite sample upper bound for L(Φnθˆn), we need the follow-
ing assumptions.
Assumption A.1. The error terms εi, i = 1, . . . , n are independent of
(Xi,Ai), i= 1, . . . , n and are i.i.d. with E(εi) = 0 and E[|εi|l]≤ l!2 cl−2σ2 for
some c, σ2 > 0 for all l≥ 2.
Assumption A.2. For all n≥ 1:
(a) there exists an 1 ≤ Un <∞ such that maxj=1,...,Jn ‖φj‖∞/σj ≤ Un,
where σj , (Eφ
2
j )
1/2.
(b) there exists an 0< η1,n <∞, such that supθ∈[θ∗n] ‖Q0−Φnθ‖∞ ≤ η1,n.
For any 0 ≤ γ < 1/2, η2,n ≥ 0 (which may depend on n) and tuning pa-
rameter λn, define
Θon =
{
θ ∈RJn :∃θo ∈ [θ∗n] s.t. ‖Φn(θ− θo)‖∞ ≤ η2,n
and max
j=1,...,Jn
∣∣∣∣E
[
Φn(θ− θo)φj
σj
]∣∣∣∣≤ γλn
}
.
24 M. QIAN AND S. A. MURPHY
Assumption A.3. For any n≥ 1, there exists a βn > 0 such that
E[Φn(θ˜− θ)]2|Mρλn(θ)| ≥ βn
[( ∑
j∈Mρλn(θ)
σj |θ˜j − θj |
)2
− ρ2|Mρλn(θ)|2λ2n
]
for all θ ∈Θon \ {0}, θ˜ ∈ RJn satisfying
∑
j∈{1,...,Jn}\Mρλn (θ)
σj |θ˜j| ≤ 2γ+51−2γ ×
(
∑
j∈Mρλn(θ)
σj |θ˜j − θj|+ ρ|Mρλn(θ)|λn).
When E(Φ
(2)
n (X,A)T |X) = 0 a.s. (Φ(2)n is defined in Section 4.1), we need
an extra assumption to derive the finite sample upper bound for the mean
square error of the treatment effect estimator E[Φ
(2)
n θˆ
(2)
n −T0(X,A)]2 (recall
that T0(X,A),Q0(X,A)−E[Q0(X,A)|X]).
Assumption A.4. For any n≥ 1, there exists a βn > 0 such that
E[Φ(2)n (θ˜
(2) − θ(2))]2|M (2)ρλn(θ)|
≥ βn
[( ∑
j∈M
(2)
ρλn
(θ)
σj |θ˜j − θj|
)2
− ρ2|M (2)ρλn(θ)|
2λ2n
]
for all θ ∈Θon \ {0}, θ˜ ∈ RJn satisfying
∑
j∈{1,...,Jn}\Mρλn (θ)
σj |θ˜j| ≤ 2γ+51−2γ ×
(
∑
j∈Mρλn(θ)
|θ˜j − θj|+ ρ|Mρλn(θ)|λn), where
M
(2)
ρλn
(θ) ∈ argmin
{M⊆{J
(1)
n +1,...,Jn} :
∑
j∈{J
(1)
n +1,...,Jn}\M
σj |θj |≤ρ|M |λn}
|M |
is the smallest index set that contains only large components in θ(2).
Without loss of generality, we assume that Assumptions A.3 and A.4 hold
with the same value of βn. And we can always choose a small enough βn so
that ρβn ≤ 1 for a given ρ.
For any given t > 0, define
Θn =
{
θ ∈Θon : |Mρλn(θ)|
(A.4)
≤ (1− 2γ)
2βn
120
[√
1
9
+
n
2U2n[log(3Jn(Jn + 1)) + t]
− 1
3
]}
.
Note that we allow Un, η1,n, η2,n and β
−1
n to increase as n increases. How-
ever, if those quantities are small, the upper bound in (A.7) will be tighter.
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Theorem A.1. Suppose Assumptions A.1 and A.2 hold. For any given
0≤ γ < 1/2, η2,n > 0, ρ≥ 0 and t > 0, let θˆn be the l1-PLS estimator defined
in (4.1) with tuning parameter
λn ≥ 8max{3c,2(η1,n + η2,n)}Un(log 6Jn + t)
(1− 2γ)n
(A.5)
+
12max{σ, (η1,n + η2,n)}
(1− 2γ)
√
2(log 6Jn + t)
n
.
Suppose Assumption A.3 holds with ρβn ≤ 1. Let Θn be the set defined in
(A.4) and assume Θn is nonempty. If
log 2Jn
n
≤ 2(1− 2γ)
2
27U2n − 10γ − 22
,(A.6)
then with probability at least 1− exp(−k′nn)− exp(−t), we have
L(Φnθˆn)≤ min
θ∈Θn
[
L(Φnθ) +Kn
|Mρλn(θ)|
βn
λ2n
]
,(A.7)
where k′n = 13(1− 2γ)2/[6(27U2n − 10γ − 22)] and Kn = [40γ(12βnρ+ 2γ +
5)]/[(1− 2γ)(2γ + 19)] + 130(12βnρ+ 2γ +5)2/[9(2γ + 19)2].
Furthermore, suppose E(Φ
(2)
n (X,A)T |X) = 0 a.s. If Assumption A.4 holds
with the same βn as that in Assumption A.3, then with probability at least
1− exp(−k′nn)− exp(−t), we have
E(Φ(2)n θˆ
(2)
n − T0)2 ≤ min
θ∈Θn
[
E(Φ(2)n θ
(2) − T0)2 +K ′n
|M (2)ρλn(θ)|
βn
λ2n
]
,
where K ′n = 20(12βnρ + 2γ + 5){γ/[(1 − 2γ)(7 − 6βnρ)] + [3(1 − 2γ)βnρ +
10(2γ +5)]/[9(2γ +19)2]}.
Remarks.
(1) Note that Kn is upper bounded by a constant under the assumption
βnρ ≤ 1. In the asymptotic setting when n→∞ and Jn →∞, (A.7) im-
plies that L(Φnθˆn)−minθ∈RJn L(Φnθ)→p 0 if (i) |Mρλn(θo)|λ2n/βn = o(1),
(ii) U2n logJn/n ≤ k1 and |Mρλn(θo)| ≤ k2βn
√
n/(U2n logJn) for some suffi-
ciently small positive constants k1 and k2 and (iii) λn ≥ k3max{1, η1,n +
η2,n}
√
logJn/n for a sufficiently large constant k3, where θ
o ∈ [θ∗n] (take
t= logJn).
(2) Below we briefly discuss Assumptions A.2–A.4.
Assumption A.2 is very similar to assumption (2) in Theorem 4.1 (which is
used to prove the concentration of the sample mean around the true mean),
except that Un and η1,n may increase as n increases. This relaxation allows
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the use of basis functions for which the sup norm maxj ‖φj‖∞ is increasing
in n [e.g., the wavelet basis used in example (4) of the simulation studies].
Assumption A.3 is a generalization of condition (4.8) [which has been
discussed in remark (4) following Theorem 4.1] to the case where Jn may
increase in n and the sparsity of a parameter is measured by the number
of “large” components as described at the beginning of this section. This
condition is used to avoid the collinearity problem. It is easy to see that
when ρ= 0 and βn is fixed in n, this assumption simplifies to condition (4.8).
Assumption A.4 puts a strengthened constraint on the linear model of the
treatment effect part, as compared to Assumption A.3. This assumption, to-
gether with Assumption A.3, is needed in deriving the upper bound for the
mean square error of the treatment effect estimator. It is easy to verify that
if E[ΦTnΦn] is positive definite, then both Assumptions A.3 and A.4 hold.
Although the result is about the treatment effect part, which is asymp-
totically independent of the main effect of X (when E[Φ
(2)
n (X,A)|X] = 0
a.s.), we still need Assumption A.3 to show that the cross product term
En[(Φ
(1)
n θˆ
(1)
n − Φ(1)n θ(1))(Φ(2)n θˆ(2)n − Φ(2)n θ(2))] is upper bounded by a quan-
tity converging to 0 at the desired rate. We may use a really poor model for
the main effect part E(Q0(X,A)|X) (e.g., Φ(1)n ≡ 1), and Assumption A.4
implies Assumption A.3 when ρ= 0. This poor model only effects the con-
stants involved in the result. When the sample size is large (so that λn
is small), the estimated ITR will be of high quality as long as T0 is well
approximated.
Proof of Theorem A.1. For any θ ∈Θn, define the events
Ω1 =
Jn⋂
j=1
{
2(1 + γ)
3
σj ≤ σˆj ≤ 2(2− γ)
3
σj
}
[where σˆj , (Enφ
2
j)
1/2],
Ω2(θ) =
{
max
j,k=1,...,Jn
∣∣∣∣(E −En)
(
φjφk
σjσk
)∣∣∣∣≤ (1− 2γ)2βn120|Mρλn (θ)|
}
,
Ω3(θ) =
{
max
j=1,...,Jn
∣∣∣∣En
[
(R−Φnθ)φj
σj
]∣∣∣∣≤ 4γ +16 λn
}
.
Then there exists a θo ∈ [θ∗n] such that
L(Φnθˆn) = L(Φnθ) + 2E[(Φnθ
o −Φnθ)Φn(θ− θˆn)] +E[Φn(θˆn − θ)]2
≤ L(Φnθ) + 2 max
j=1,...,Jn
∣∣∣∣E
[
Φn(θ
o − θ)φj
σj
]∣∣∣∣
(
Jn∑
j=1
σj |θˆn,j − θj|
)
+E[Φn(θˆn − θ)]2
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≤ L(Φnθ) + 2γλn
(
Jn∑
j=1
σj|θˆn,j − θj|
)
+E[Φn(θˆn − θ)]2,
where the first equality follows from the fact that E[(R−Φnθo)φj ] = 0 for
any θo ∈ [θ∗n] for j = 1, . . . , Jn and the last inequality follows from the defi-
nition of Θon.
Based on Lemma A.1 below, we have that on the event Ω1∩Ω2(θ)∩Ω3(θ),
L(Φnθˆn)≤ L(Φnθ) +Kn
|Mρλn(θ)|
βn
λ2n.
Similarly, when E[Φ
(2)
2 (X,A)
T |X] = 0, by Lemma A.2, we have that on
the event Ω1 ∩Ω2(θ)∩Ω3(θ),
E(Φ(2)n θˆ
(2)
n − T0)2 ≤ E(Φ(2)n θ(2) − T0)2 +2γλn
(
Jn∑
j=J
(1)
n +1
σj|θˆn,j − θj |
)
+E[Φ(2)n (θˆ
(2)
n − θ(2))]2
≤ E(Φ(2)n θ(2) − T0)2 +K ′n
|M (2)ρλn(θ)|
βn
λ2n.
The conclusion of the theorem follows from the union probability bounds
of the events Ω1, Ω2(θ) and Ω3(θ) provided in Lemmas A.3, A.4 and A.5.

Below we state the lemmas used in the proof of Theorem A.1. The proofs
of the lemmas are given in Section S.4 of the supplemental article [25].
Lemma A.1. Suppose Assumption A.3 holds with ρβn ≤ 1. Then for any
θ ∈Θn, on the event Ω1 ∩Ω2(θ)∩Ω3(θ), we have
Jn∑
j=1
σj |θˆn,j − θj| ≤ 20(12ρβn + 2γ +5)
(1− 2γ)(19 + 2γ)βn |Mρλn(θ)|λn(A.8)
and
E[Φn(θˆn − θ)]2 ≤ 130(12ρβn + 2γ +5)
2
9(19 + 2γ)2βn
|Mρλn(θ)|λ2n(A.9)
Remark. This lemma implies that θˆn is close to each θ ∈ Θn on the
event Ω1∩Ω2(θ)∩Ω3(θ). The intuition is as follows. Since θˆn minimizes (4.1),
the first order conditions imply that maxj |En(R−Φnθˆn)φj/σˆj | ≤ λn/2. Sim-
ilar property holds for θ on the event Ω1 ∩Ω3(θ). Assumption A.3 together
with event Ω2(θ) ensures that there is no collinearity in the n× Jn design
matrix (Φn(Xi,Ai))
n
i=1. These two aspects guarantee the closeness of θˆn
to θ.
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Lemma A.2. Suppose E[Φ
(2)
n (X,A)T |X] = 0 a.s. and Assumptions A.3
and A.4 hold with ρβn ≤ 1. Then for any θ ∈Θn, on the event Ω1 ∩Ω2(θ)∩
Ω3(θ), we have
Jn∑
j=J
(1)
n +1
σj |θˆn,j − θj| ≤ 10(12βnρ+2γ +5)
(1− 2γ)(7− 6βnρ)βn |M
(2)
ρλn
(θ)|λn(A.10)
and
E[Φ(2)n (θˆ
(2)
n − θ(2))]2
(A.11)
≤ 20(12ρβn +2γ +5)[3(1− 2γ)βnρ+ 10(2γ + 5)]
9(2γ + 19)2βn
|M (2)ρλn(θ)|λ2n.
Lemma A.3. Suppose Assumption A.2(a) and inequality (A.6) hold.
Then P(ΩC1 )≤ exp(−k′nn), where k′n = 13(1− 2γ)2/[6(27U2n − 10γ − 22)].
Lemma A.4. Suppose Assumption A.2(a) holds. Then for any t > 0 and
θ ∈Θn, P({Ω2(θ)}C)≤ exp(−t)/3.
Lemma A.5. Suppose Assumptions A.1 and A.2 hold. For any t > 0, if
λn satisfies condition (A.5), then for any θ ∈Θn, we have P({Ω3(θ)}C)≤
2exp(−t)/3.
A.3. Design of simulations in Section 5.1. In this section, we present
the detailed simulation design of the examples used in Section 5.1. These
examples satisfy all assumptions listed in the theorems [it is easy to verify
that for examples (1)–(3). Validity of the assumptions for example (4) is
addressed in the remark after example (4)]. In addition, Θn defined in (4.4)
is nonempty as long as n is sufficiently large (note that the constants in-
volved in Θn can be improved and are not that meaningful. We focused on
a presentable result instead of finding the best constants).
In examples (1)–(3), X = (X1, . . . ,X5) is uniformly distributed on [−1,1]5.
The treatment A is then generated independently of X uniformly from
{−1,1}. Given X and A, the response R is generated from a normal distribu-
tion with mean Q0(X,A) = 1+2X1+X2+0.5X3+T0(X,A) and variance 1.
We consider the following three examples for T0:
(1) T0(X,A) = 0 (i.e., there is no treatment effect).
(2) T0(X,A) = 0.424(1−X1 −X2)A.
(3) T0(X,A) = 0.446 sign(X1)(1−X1)2A.
Note that in each example T0(X,A) is equal to the treatment effect term,
Q0(X,A) − E[Q0(X,A)|X]. We approximate Q0 by Q = {(1,X,A,XA)θ :
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θ ∈ R12}. Thus, in examples (1) and (2) the treatment effect term T0 is
correctly modeled, while in example (3) the treatment effect term T0 is
misspecified.
The parameters in examples (2) and (3) are chosen to reflect a medium
effect size according to Cohen’s d index. When there are two treatments,
the Cohen’s d effect size index is defined as the standardized difference in
mean responses between two treatment groups, that is,
es =
E(R|A= 1)−E(R|A=−1)
([Var(R|A= 1) +Var(R|A=−1)]/2)1/2 .
Cohen [7] tentatively defined the effect size as “small” if the Cohen’s d index
is 0.2, “medium” if the index is 0.5 and “large” if the index is 0.8.
In example (4), X is uniformly distributed on [0,1]. Treatment A is
generated independently of X uniformly from {−1,1}. The response R is
generated from a normal distribution with mean Q0(X,A) and variance 1,
where Q0(X,1) =
∑8
j=1 ϑ(1),j1X<u(1),j , Q0(X,−1) =
∑8
j=1 ϑ(−1),j1X<u(−1),j ,
and ϑ’s and u’s are parameters specified in (A.12). The effect size is small:
(ϑ(1),1, . . . , ϑ(1),8)
= (−0.781,0.730,0.635,0.512,−2.278,1.347,1.155,−0.030);
(ϑ(−1),1, . . . , ϑ(−1),8)
= (−2.068,1.520,−0.072,
−0.637,1.003,−0.611,−0.305,1.016);(A.12)
(u(1),1, . . . , u(1),8)
= (0.028,0.144,0.171, 0.298, 0.421, 0.443,0.463,0.758);
(u(−1),1, . . . , u(−1),8)
= (0.061,0.215,0.492, 0.544, 0.6302,0.650,0.785,0.909).
We approximate Q0 by Haar wavelets,
θ(0),0h0(X) +
∑
lk
θ(0),lkhlk(X) +
(
θ(0),1h0(X) +
∑
lk
θ(1),lkhlk(X)
)
A,
where h0(x) = 1x∈[0,1] and hlk(x) = 2
l/2(12lx∈[k+1/2,k+1) − 12lx∈[k,k+1/2)) for
l = 0, . . . , l¯n, and θ(·),· ∈ R are parameters. We choose l¯n = ⌊3 log2 n/4⌋ −
2. For a given l and sample (Xi,Ai,Ri)
n
i=1, k takes integer values from
⌊2lminiXi⌋ to ⌈2lmaxiXi⌉ − 1. Then Jn = 2⌊3 log2 n/4⌋ ≤ n3/4.
Remark. In example (4), we allow the number of basis functions Jn to
increase with n. The corresponding theoretical result can be obtained by
30 M. QIAN AND S. A. MURPHY
combining Theorems 3.1 and A.1. Below we demonstrate the validation of
the assumptions used in the theorems.
Theorem 3.1 requires that the randomization probability p(a|x) ≥ S−1
for a positive constant for all (x,a) pairs and the margin condition (3.3) or
(3.6) holds. According the generative model, we have that p(a|x) = 1/2 and
condition (3.6) holds.
Theorem A.1 requires Assumptions A.1–A.4 hold and Θn defined in (A.4)
is nonempty. Since we consider normal error terms, Assumption A.1 holds.
Note that the basis functions used in Haar wavelet are orthogonal. It is also
easy to verify that Assumptions A.3 and A.4 hold with βn = 1 and Assump-
tion A.2 holds with Un = n
3/8/2 and η1,n ≤ constant + constant × ‖θ∗n‖0
[since each |φjθ∗n,j| = |φjE(φjR)| ≤ constant × |φj |E|φj | ≤ O(1)]. Since Q0
is piece-wise constant, we can also verify that ‖θ∗n‖0 ≤ O(logn). Thus, for
sufficiently large n, Θn is nonempty and (A.6) holds. The RHS of (A.5)
converges to zero as n→∞.
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SUPPLEMENTARY MATERIAL
Supplement to “Performance guarantees for individualized treatment
rules” (DOI: 10.1214/10-AOS864SUPP; .pdf). This supplement contains
four sections. Section S.1 discusses the problem with over-fitting due to the
potentially large number of pretreatment variables (and/or complex approx-
imation space for Q0) mentioned in Section 4. Section S.2 provides modifi-
cations of the l1-PLS estimator θˆn when some coefficients are not penalized
and discusses how to obtain results similar to inequality (A.7) in this case.
Section S.3 provides extra four simulation examples based on data from the
Nefazodone-CBASP trial [13]. Section S.4 provides proofs of Lemmas A.1–
A.5.
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